[1]黄 婷,张亚莉,李 燕,等.不同性别IgA肾病患者相关临床指标及病理特点对比[J].医学信息,2019,32(21):125-128.[doi:10.3969/j.issn.1006-1959.2019.21.040]
　HUANG Ting,ZHANG Ya-li,LI Yan,et al.Comparative Analysis of Clinical and Pathological Features of Patients with Different Sex IgA Nephropathy[J].Journal of Medical Information,2019,32(21):125-128.[doi:10.3969/j.issn.1006-1959.2019.21.040]
点击复制

不同性别IgA肾病患者相关临床指标及病理特点对比()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年21期
页码:
125-128
栏目:
调查分析
出版日期:
2019-11-01

文章信息/Info

Title:
Comparative Analysis of Clinical and Pathological Features of Patients with Different Sex IgA Nephropathy
文章编号:
1006-1959（2019）21-0125-04
作者:
黄 婷1; 张亚莉1; 李 燕1; 王文涛2
（1.西安交通大学第一附属医院肾内科，陕西 西安 710061；2.西安第九人民医院肾脏内科，陕西 西安 710000）
Author(s):
HUANG Ting1; ZHANG Ya-li1; LI Yan1; WANG Wen-tao2
(1.Department of Nephrology,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,Shaanxi,China;2.Department of Nephrology,Xi'an Ninth People's Hospital,Xi'an 710000,Shaanxi,China)
关键词:
IgA肾病; 性别; 临床指标; 病理特点
Keywords:
IgA nephropathy; Gender; Clinical indicators; Pathological features
分类号:
R692.3
DOI:
10.3969/j.issn.1006-1959.2019.21.040
文献标志码:
A
摘要:
目的 通过对不同性别IgA肾病患者临床指标及病理特点的对比，了解性别间相关指标的差异，为临床积极有效的治疗该病提供依据。方法 回顾性分析2017年1月1日~2018年8月30日我院经肾穿刺活检确诊的361例IgA肾病患者的临床资料，比较不同性别IgA肾病患者的临床资料、危险度分级、病理分级及免疫荧光分型。结果 不同性别IgA肾病患者年龄、病程、舒张压、水肿、血尿、蛋白尿、血尿+蛋白尿、白蛋白、IgA、IgG、IgM、IgE、C3、C4、IgA/C3、肾小球滤过率、血钾、血钙、血磷、APTT、PT、FIB、左肾及右肾大小比较，差异无统计学意义（P＞0.05）；男性收缩压、血压高、肾功异常占比、胱抑素、肌酐、尿素、尿酸、甘油三脂、胆固醇、血钠、尿蛋白定量高于女性，差异有统计学意义（P＜0.05）。不同性别IgA肾病患者在1~3级占比比较，差异无统计学意义（P＞0.05）；男性IgA肾病患者在4级占比多于女性，差异有统计学意义（P＜0.05）。不同性别IgA肾病患者病理分级比较，差异无统计学意义（P＞0.05）。不同性别IgA肾病患者在IgA+IgM+C3、IgA+IgM+IgG、IgA+IgM+IlgG+C3占比比较，差异无统计学意义（P＞0.05）；男性IgA肾病患者在IgA+IgG+C3、IgA+C3分型中占比多于女性，差异有统计学意义（P＜0.05）。结论 男性IgA肾病的发病人数多于女性，且在IgA肾病中，男性的肾功能较女性差，推测其预后可能较差，因此当男性确诊为IgA肾病后，应更加关注其临床指标及病理相关指标，及早干预、及早治疗，制定合理地个性化治疗方案，延缓其进展。
Abstract:
Objective To compare the clinical indicators and pathological features of patients with different gender IgA nephropathy, and to understand the differences between gender-related indicators, so as to provide a basis for clinically effective treatment of the disease. Methods The clinical data of 361 patients with IgA nephropathy diagnosed by renal biopsy from January 1, 2017 to August 30, 2018 were retrospectively analyzed. The clinical data, risk grading and pathological grading of patients with different gender IgA nephropathy were compared. And immunofluorescence typing. Results Age, duration, diastolic blood pressure, edema, hematuria, proteinuria, hematuria + proteinuria, albumin, IgA, IgG,IgM,IgE, C3, C4, IgA/C3, glomerular filtration rate, IgA nephropathy there was no significant difference in serum potassium, serum calcium, blood phosphorus, APTT, PT, FIB, left kidney and right kidney (P>0.05); Male systolic blood pressure, high blood pressure, abnormal renal function, cystatin, creatinine, urea, uric acid, triglyceride, cholesterol, blood sodium, urine protein were higher than females, the difference was statistically significant (P<0.05).There was no significant difference in the proportion of IgA nephropathy patients with grade I to grade 3 (P>0.05). The proportion of male IgA nephropathy patients was higher than that of females at 4th grade,the difference was statistically significant (P<0.05). There was no significant difference in pathological grade between patients with different gender IgA nephropathy (P>0.05). There were no significant differences in the proportion of IgA+IgM+C3,IgA+IgM+IgG, IgA+IgM+IgG+C3 in patients with different gender IgA nephropathy (P>0.05). IgA+IgG+C3 in male IgA nephropathy patients the proportion of IgA+C3 classification was higher than that of females,the difference was statistically significant (P<0.05). Conclusion The incidence of IgA nephropathy in men is higher than that in women. In IgA nephropathy, the renal function of men is worse than that of women. It is speculated that the prognosis may be poor. Therefore, when men are diagnosed with IgA nephropathy, they should pay more attention to their clinical indicators and pathological correlation. Indicators, early intervention, early treatment, and rationalized personalized treatment programs to delay their progress.

参考文献/References:

[1]田向辉,高丹,娄岩,等.性别与原发性IgA肾病临床及病理特点关系研究[J].中国实验诊断学,2018,22(8):1400-1402. [2]周悦玲,蒋更如.IgA肾病进展至终末期肾病临床预测的研究现状[J].上海交通大学学报(医学版),2016,36(2):296-301. [3]王芳,丁洁.原发性IgA肾病诊治循证指南(2016)解读[J].中华儿科杂志,2017,55(9):652-653. [4]Mubarak M,Nasri H,Rafieian-Kopaei M.Comment on:IgA nephropathy with early kidney disease is associated with increased arterial stiffness and renin-angiotensin system activity[J].J Renin Angiotensin Aldosterone Syst,2015,16(4):965-966. [5]涂宁芳,袁雅玲,龚龙.IgA肾病牛津病理分型特点及对疾病预后影响分析[J].中国继续医学教育,2019,11(2):63-66. [6]Zhou S,Fu J,Liu M,et al.The prevalence and risk factors of abnormal circadian blood pressure in patients with IgA nephropathy[J].Clin Nephrol,2017,88(12):344-353。 [7]Liu Y,Ma X,Lv J,et al.Risk factors for pregnancy outcomes in patients with IgA nephropathy:a matched cohort study[J].Am J Kidney Dis,2014,64(5):730-736. [8]Mahanta PJ,Agarawalla B,Sharma M.Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury: A single-center retrospective study[J].Saudi J Kidney Dis Transpl,2019,30(2):445-450. [9]王文涛,黄婷,何堤,等.成人原发性IgA肾病与血免疫球蛋白及补体的相关关系[J].山西医科大学学报,2018,49(8):963-967.

相似文献/References:

[1]李露娜,周青松.不同性别OSAHS患者的睡眠质量对血压的影响[J].医学信息,2018,31(20):69.[doi:10.3969/j.issn.1006-1959.2018.20.020]
　LI Lu-na,ZHOU Qing-song.Effect of Sleep Quality on Blood Pressure in OSAHS Patients with Different Genders[J].Journal of Medical Information,2018,31(21):69.[doi:10.3969/j.issn.1006-1959.2018.20.020]
[2]唐菁娟,赖镜华.湛江市区学龄前儿童25-羟维生素D水平研究[J].医学信息,2019,32(07):137.[doi:10.3969/j.issn.1006-1959.2019.07.041]
　TANG Jing-juan,LAI Jing-hua.Study on 25-hydroxyvitamin D Levels in Preschool Children in Zhanjiang City[J].Journal of Medical Information,2019,32(21):137.[doi:10.3969/j.issn.1006-1959.2019.07.041]
[3]杜 敏.定量测定抗链球菌溶血素“O”的检测分析[J].医学信息,2019,32(17):180.[doi:10.3969/j.issn.1006-1959.2019.17.062]
　DU Min.Quantitative Determination of Anti-streptolysin"O"[J].Journal of Medical Information,2019,32(21):180.[doi:10.3969/j.issn.1006-1959.2019.17.062]
[4]陈 越,彭 莉.黄芪对细胞毒素相关蛋白A诱导的大鼠系膜细胞外基质分泌的影响[J].医学信息,2022,35(15):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
　CHEN Yue,PENG Li.Effect of Astragalus Membranaceus on CagA-induced Extracellular Matrix Secretion of Rat Mesangial Cells[J].Journal of Medical Information,2022,35(21):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
[5]刘 枫.IgA肾病与系膜增生性肾炎临床特征的比较[J].医学信息,2019,32(16):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
　LIU Feng.Comparison of Clinical Features between IgA Nephropathy and Mesangial Proliferative Nephritis[J].Journal of Medical Information,2019,32(21):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
[6]姜爱华,李 辉.无偿献血者发生献血不良反应与性别和采血时间的关系[J].医学信息,2020,33(11):139.[doi:10.3969/j.issn.1006-1959.2020.11.044]
　JIANG Ai-hua,LI Hui.Relationship Between Unpaid Blood Donors’ Adverse Blood Donation Reactions with Gender and Blood Collection Time[J].Journal of Medical Information,2020,33(21):139.[doi:10.3969/j.issn.1006-1959.2020.11.044]
[7]李丽艳,崔 雯.北京京煤集团总医院健康体检者血清AFP检测结果分析[J].医学信息,2020,33(17):131.[doi:10.3969/j.issn.1006-1959.2020.17.037]
　LI Li-yan,CUI Wen.Analysis of Serum AFP Test Results of Healthy Physical Examination in Beijing Jingmei Group General Hospital[J].Journal of Medical Information,2020,33(21):131.[doi:10.3969/j.issn.1006-1959.2020.17.037]
[8]刘永芳,王 莹.付义主任治疗IgA肾病经验[J].医学信息,2020,33(21):155.[doi:10.3969/j.issn.1006-1959.2020.21.048]
[9]刘 俊,严 婷,刘 红,等.2013~2019年广州某院消化系统恶性肿瘤流行病学分析[J].医学信息,2020,33(23):137.[doi:10.3969/j.issn.1006-1959.2020.23.040]
　LIU Jun,YAN Ting,LIU Hong,et al.Epidemiological Analysis of Malignant Tumors of the Digestive System in a Hospital in Guangzhou from 2013 to 2019[J].Journal of Medical Information,2020,33(21):137.[doi:10.3969/j.issn.1006-1959.2020.23.040]
[10]郑桌龙,林 钢,罗勉那,等.成人IgA肾病免疫抑制治疗的研究进展[J].医学信息,2023,36(14):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
　ZHENG Zhuo-long,LIN Gang,LUO Mian-na,et al.Research Progress on Immunosuppressive Therapy for IgA Nephropathy in Adults[J].Journal of Medical Information,2023,36(21):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]

更新日期/Last Update: 2019-11-01